nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAPK8—endothelium—Behcet's disease	0.0102	0.0171	CbGeAlD
Nilotinib—MAPK8—blood vessel—Behcet's disease	0.00942	0.0158	CbGeAlD
Nilotinib—TIE1—endothelium—Behcet's disease	0.00886	0.0149	CbGeAlD
Nilotinib—TIE1—blood vessel—Behcet's disease	0.00817	0.0137	CbGeAlD
Nilotinib—MAPK8—mouth—Behcet's disease	0.00788	0.0132	CbGeAlD
Nilotinib—TEK—artery—Behcet's disease	0.00697	0.0117	CbGeAlD
Nilotinib—EPHB2—brainstem—Behcet's disease	0.00644	0.0108	CbGeAlD
Nilotinib—EPHB2—retina—Behcet's disease	0.00621	0.0104	CbGeAlD
Nilotinib—EPHB4—endothelium—Behcet's disease	0.00615	0.0103	CbGeAlD
Nilotinib—EPHA8—eye—Behcet's disease	0.00601	0.0101	CbGeAlD
Nilotinib—MAPK14—blood vessel—Behcet's disease	0.00598	0.01	CbGeAlD
Nilotinib—TEK—endothelium—Behcet's disease	0.00588	0.00987	CbGeAlD
Nilotinib—EPHB4—blood vessel—Behcet's disease	0.00567	0.00951	CbGeAlD
Nilotinib—CA6—mouth—Behcet's disease	0.00566	0.0095	CbGeAlD
Nilotinib—EPHA2—blood vessel—Behcet's disease	0.00556	0.00933	CbGeAlD
Nilotinib—CDC42BPB—eye—Behcet's disease	0.00554	0.0093	CbGeAlD
Nilotinib—CDC42BPB—retina—Behcet's disease	0.00549	0.00922	CbGeAlD
Nilotinib—EPHA4—mouth—Behcet's disease	0.00543	0.00911	CbGeAlD
Nilotinib—TEK—blood vessel—Behcet's disease	0.00543	0.00911	CbGeAlD
Nilotinib—CA3—mouth—Behcet's disease	0.00536	0.009	CbGeAlD
Nilotinib—EPHA3—eye—Behcet's disease	0.00525	0.00882	CbGeAlD
Nilotinib—EPHA3—retina—Behcet's disease	0.00521	0.00874	CbGeAlD
Nilotinib—MAPK8—brainstem—Behcet's disease	0.00515	0.00864	CbGeAlD
Nilotinib—MAPK8—eye—Behcet's disease	0.00501	0.00841	CbGeAlD
Nilotinib—MAPK14—mouth—Behcet's disease	0.00501	0.0084	CbGeAlD
Nilotinib—MAPK8—retina—Behcet's disease	0.00497	0.00833	CbGeAlD
Nilotinib—MAP4K1—retina—Behcet's disease	0.00451	0.00757	CbGeAlD
Nilotinib—MAPK8—skin of body—Behcet's disease	0.00436	0.00732	CbGeAlD
Nilotinib—KIT—endothelium—Behcet's disease	0.00426	0.00715	CbGeAlD
Nilotinib—EPHB3—brainstem—Behcet's disease	0.00425	0.00712	CbGeAlD
Nilotinib—CDC42BPB—cardiac atrium—Behcet's disease	0.00421	0.00707	CbGeAlD
Nilotinib—CDC42BPB—medulla oblongata—Behcet's disease	0.00397	0.00666	CbGeAlD
Nilotinib—KIT—blood vessel—Behcet's disease	0.00393	0.00659	CbGeAlD
Nilotinib—PDGFRB—blood vessel—Behcet's disease	0.00384	0.00644	CbGeAlD
Nilotinib—CDC42BPB—midbrain—Behcet's disease	0.00363	0.00609	CbGeAlD
Nilotinib—MAP4K1—mammalian vulva—Behcet's disease	0.00361	0.00606	CbGeAlD
Nilotinib—MAPK8—medulla oblongata—Behcet's disease	0.00359	0.00602	CbGeAlD
Nilotinib—EPHA4—brainstem—Behcet's disease	0.00355	0.00595	CbGeAlD
Nilotinib—CDC42BPB—spinal cord—Behcet's disease	0.00354	0.00594	CbGeAlD
Nilotinib—EPHB2—nervous system—Behcet's disease	0.00337	0.00566	CbGeAlD
Nilotinib—TIE1—cardiac atrium—Behcet's disease	0.0033	0.00554	CbGeAlD
Nilotinib—KIT—mouth—Behcet's disease	0.00329	0.00552	CbGeAlD
Nilotinib—MAPK8—midbrain—Behcet's disease	0.00328	0.00551	CbGeAlD
Nilotinib—EPHB3—mammalian vulva—Behcet's disease	0.00328	0.0055	CbGeAlD
Nilotinib—MAPK14—brainstem—Behcet's disease	0.00327	0.00549	CbGeAlD
Nilotinib—EPHB2—central nervous system—Behcet's disease	0.00325	0.00545	CbGeAlD
Nilotinib—EPHA8—nervous system—Behcet's disease	0.00324	0.00543	CbGeAlD
Nilotinib—MAPK8—spinal cord—Behcet's disease	0.0032	0.00537	CbGeAlD
Nilotinib—EPHA8—central nervous system—Behcet's disease	0.00311	0.00523	CbGeAlD
Nilotinib—HCK—mammalian vulva—Behcet's disease	0.00301	0.00506	CbGeAlD
Nilotinib—MAPK11—nervous system—Behcet's disease	0.00301	0.00505	CbGeAlD
Nilotinib—CDC42BPB—nervous system—Behcet's disease	0.00298	0.005	CbGeAlD
Nilotinib—MAPK11—central nervous system—Behcet's disease	0.0029	0.00486	CbGeAlD
Nilotinib—CDC42BPB—central nervous system—Behcet's disease	0.00287	0.00482	CbGeAlD
Nilotinib—EPHA3—nervous system—Behcet's disease	0.00283	0.00474	CbGeAlD
Nilotinib—MAPK14—skin of body—Behcet's disease	0.00277	0.00465	CbGeAlD
Nilotinib—EPHA4—mammalian vulva—Behcet's disease	0.00274	0.0046	CbGeAlD
Nilotinib—BRAF—midbrain—Behcet's disease	0.00273	0.00458	CbGeAlD
Nilotinib—EPHA3—central nervous system—Behcet's disease	0.00272	0.00457	CbGeAlD
Nilotinib—HCK—medulla oblongata—Behcet's disease	0.00272	0.00457	CbGeAlD
Nilotinib—MAPK8—nervous system—Behcet's disease	0.0027	0.00453	CbGeAlD
Nilotinib—EPHA6—nervous system—Behcet's disease	0.0027	0.00453	CbGeAlD
Nilotinib—EPHB3—spinal cord—Behcet's disease	0.00264	0.00443	CbGeAlD
Nilotinib—EPHA4—cardiac atrium—Behcet's disease	0.00262	0.0044	CbGeAlD
Nilotinib—MAPK8—central nervous system—Behcet's disease	0.0026	0.00436	CbGeAlD
Nilotinib—EPHA6—central nervous system—Behcet's disease	0.0026	0.00436	CbGeAlD
Nilotinib—CA3—cardiac atrium—Behcet's disease	0.00259	0.00435	CbGeAlD
Nilotinib—EPHB2—brain—Behcet's disease	0.00258	0.00433	CbGeAlD
Nilotinib—FGR—mammalian vulva—Behcet's disease	0.00252	0.00422	CbGeAlD
Nilotinib—LCK—mammalian vulva—Behcet's disease	0.00252	0.00422	CbGeAlD
Nilotinib—LYN—nervous system—Behcet's disease	0.00249	0.00418	CbGeAlD
Nilotinib—HCK—midbrain—Behcet's disease	0.00249	0.00417	CbGeAlD
Nilotinib—EPHA4—medulla oblongata—Behcet's disease	0.00247	0.00415	CbGeAlD
Nilotinib—EPHA8—brain—Behcet's disease	0.00247	0.00415	CbGeAlD
Nilotinib—CA7—midbrain—Behcet's disease	0.00243	0.00408	CbGeAlD
Nilotinib—HCK—spinal cord—Behcet's disease	0.00243	0.00407	CbGeAlD
Nilotinib—MAP2K5—brainstem—Behcet's disease	0.00242	0.00407	CbGeAlD
Nilotinib—CA12—eye—Behcet's disease	0.00242	0.00405	CbGeAlD
Nilotinib—EPHB6—skin of body—Behcet's disease	0.0024	0.00403	CbGeAlD
Nilotinib—LYN—central nervous system—Behcet's disease	0.0024	0.00402	CbGeAlD
Nilotinib—EPHB4—mammalian vulva—Behcet's disease	0.00239	0.00402	CbGeAlD
Nilotinib—CA14—cardiac atrium—Behcet's disease	0.00235	0.00395	CbGeAlD
Nilotinib—EPHA2—mammalian vulva—Behcet's disease	0.00235	0.00394	CbGeAlD
Nilotinib—TIE1—nervous system—Behcet's disease	0.00234	0.00392	CbGeAlD
Nilotinib—CSF1R—eye—Behcet's disease	0.0023	0.00386	CbGeAlD
Nilotinib—MAPK11—brain—Behcet's disease	0.0023	0.00386	CbGeAlD
Nilotinib—EPHB4—cardiac atrium—Behcet's disease	0.00229	0.00385	CbGeAlD
Nilotinib—CDC42BPB—brain—Behcet's disease	0.00228	0.00383	CbGeAlD
Nilotinib—TIE1—central nervous system—Behcet's disease	0.00225	0.00378	CbGeAlD
Nilotinib—EPHA2—cardiac atrium—Behcet's disease	0.00225	0.00377	CbGeAlD
Nilotinib—EPHB3—nervous system—Behcet's disease	0.00222	0.00373	CbGeAlD
Nilotinib—CA14—medulla oblongata—Behcet's disease	0.00222	0.00372	CbGeAlD
Nilotinib—TEK—cardiac atrium—Behcet's disease	0.00219	0.00368	CbGeAlD
Nilotinib—EPHB6—mammalian vulva—Behcet's disease	0.00219	0.00367	CbGeAlD
Nilotinib—EPHB4—medulla oblongata—Behcet's disease	0.00216	0.00363	CbGeAlD
Nilotinib—EPHA3—brain—Behcet's disease	0.00216	0.00363	CbGeAlD
Nilotinib—KIT—brainstem—Behcet's disease	0.00215	0.0036	CbGeAlD
Nilotinib—EPHB3—central nervous system—Behcet's disease	0.00214	0.00359	CbGeAlD
Nilotinib—EPHB6—cardiac atrium—Behcet's disease	0.0021	0.00352	CbGeAlD
Nilotinib—TEK—medulla oblongata—Behcet's disease	0.00207	0.00347	CbGeAlD
Nilotinib—EPHA6—brain—Behcet's disease	0.00206	0.00346	CbGeAlD
Nilotinib—MAPK8—brain—Behcet's disease	0.00206	0.00346	CbGeAlD
Nilotinib—HCK—nervous system—Behcet's disease	0.00204	0.00343	CbGeAlD
Nilotinib—PDGFRB—eye—Behcet's disease	0.00204	0.00343	CbGeAlD
Nilotinib—MAPK14—spinal cord—Behcet's disease	0.00203	0.00341	CbGeAlD
Nilotinib—CA14—midbrain—Behcet's disease	0.00203	0.0034	CbGeAlD
Nilotinib—CSF1R—skin of body—Behcet's disease	0.002	0.00336	CbGeAlD
Nilotinib—CA14—spinal cord—Behcet's disease	0.00198	0.00332	CbGeAlD
Nilotinib—EPHB6—medulla oblongata—Behcet's disease	0.00198	0.00332	CbGeAlD
Nilotinib—EPHB4—midbrain—Behcet's disease	0.00198	0.00331	CbGeAlD
Nilotinib—HCK—central nervous system—Behcet's disease	0.00197	0.0033	CbGeAlD
Nilotinib—CA2—mouth—Behcet's disease	0.00195	0.00327	CbGeAlD
Nilotinib—EPHB4—spinal cord—Behcet's disease	0.00193	0.00323	CbGeAlD
Nilotinib—CA1—eye—Behcet's disease	0.00191	0.00321	CbGeAlD
Nilotinib—LYN—brain—Behcet's disease	0.0019	0.00319	CbGeAlD
Nilotinib—TEK—midbrain—Behcet's disease	0.00189	0.00317	CbGeAlD
Nilotinib—MAP4K1—brain—Behcet's disease	0.00187	0.00314	CbGeAlD
Nilotinib—MAP2K5—mammalian vulva—Behcet's disease	0.00187	0.00314	CbGeAlD
Nilotinib—ABL1—brainstem—Behcet's disease	0.00187	0.00314	CbGeAlD
Nilotinib—EPHA4—nervous system—Behcet's disease	0.00186	0.00312	CbGeAlD
Nilotinib—TEK—spinal cord—Behcet's disease	0.00184	0.00309	CbGeAlD
Nilotinib—CA3—nervous system—Behcet's disease	0.00184	0.00308	CbGeAlD
Nilotinib—CSF1R—mammalian vulva—Behcet's disease	0.00183	0.00307	CbGeAlD
Nilotinib—ABL1—eye—Behcet's disease	0.00182	0.00306	CbGeAlD
Nilotinib—KIT—skin of body—Behcet's disease	0.00182	0.00305	CbGeAlD
Nilotinib—EPHB6—midbrain—Behcet's disease	0.00181	0.00303	CbGeAlD
Nilotinib—ABL1—retina—Behcet's disease	0.0018	0.00303	CbGeAlD
Nilotinib—MAP2K5—cardiac atrium—Behcet's disease	0.00179	0.00301	CbGeAlD
Nilotinib—EPHA4—central nervous system—Behcet's disease	0.00179	0.003	CbGeAlD
Nilotinib—TIE1—brain—Behcet's disease	0.00179	0.003	CbGeAlD
Nilotinib—PDGFRB—skin of body—Behcet's disease	0.00178	0.00298	CbGeAlD
Nilotinib—CA3—central nervous system—Behcet's disease	0.00177	0.00296	CbGeAlD
Nilotinib—EPHB6—spinal cord—Behcet's disease	0.00176	0.00296	CbGeAlD
Nilotinib—CSF1R—cardiac atrium—Behcet's disease	0.00175	0.00294	CbGeAlD
Nilotinib—BRAF—brain—Behcet's disease	0.00171	0.00288	CbGeAlD
Nilotinib—MAPK14—nervous system—Behcet's disease	0.00171	0.00287	CbGeAlD
Nilotinib—FGR—nervous system—Behcet's disease	0.00171	0.00286	CbGeAlD
Nilotinib—EPHB3—brain—Behcet's disease	0.0017	0.00285	CbGeAlD
Nilotinib—MAP2K5—medulla oblongata—Behcet's disease	0.00169	0.00284	CbGeAlD
Nilotinib—PDGFRA—spinal cord—Behcet's disease	0.00167	0.0028	CbGeAlD
Nilotinib—KIT—mammalian vulva—Behcet's disease	0.00166	0.00278	CbGeAlD
Nilotinib—CSF1R—medulla oblongata—Behcet's disease	0.00165	0.00277	CbGeAlD
Nilotinib—MAPK14—central nervous system—Behcet's disease	0.00165	0.00277	CbGeAlD
Nilotinib—FGR—central nervous system—Behcet's disease	0.00164	0.00276	CbGeAlD
Nilotinib—PDGFRB—mammalian vulva—Behcet's disease	0.00162	0.00272	CbGeAlD
Nilotinib—EPHA2—nervous system—Behcet's disease	0.00159	0.00267	CbGeAlD
Nilotinib—ABL1—skin of body—Behcet's disease	0.00158	0.00266	CbGeAlD
Nilotinib—HCK—brain—Behcet's disease	0.00156	0.00262	CbGeAlD
Nilotinib—TEK—nervous system—Behcet's disease	0.00155	0.00261	CbGeAlD
Nilotinib—ABL2—brain—Behcet's disease	0.00155	0.00261	CbGeAlD
Nilotinib—PDGFRB—cardiac atrium—Behcet's disease	0.00155	0.0026	CbGeAlD
Nilotinib—MAP2K5—midbrain—Behcet's disease	0.00155	0.00259	CbGeAlD
Nilotinib—CA4—brainstem—Behcet's disease	0.00154	0.00258	CbGeAlD
Nilotinib—EPHA2—central nervous system—Behcet's disease	0.00153	0.00257	CbGeAlD
Nilotinib—CA7—brain—Behcet's disease	0.00153	0.00257	CbGeAlD
Nilotinib—CSF1R—midbrain—Behcet's disease	0.00151	0.00253	CbGeAlD
Nilotinib—MAP2K5—spinal cord—Behcet's disease	0.00151	0.00253	CbGeAlD
Nilotinib—KIT—medulla oblongata—Behcet's disease	0.0015	0.00251	CbGeAlD
Nilotinib—TEK—central nervous system—Behcet's disease	0.0015	0.00251	CbGeAlD
Nilotinib—EPHB6—nervous system—Behcet's disease	0.00149	0.00249	CbGeAlD
Nilotinib—CSF1R—spinal cord—Behcet's disease	0.00147	0.00247	CbGeAlD
Nilotinib—PDGFRB—medulla oblongata—Behcet's disease	0.00146	0.00246	CbGeAlD
Nilotinib—ABL1—mammalian vulva—Behcet's disease	0.00144	0.00242	CbGeAlD
Nilotinib—EPHB6—central nervous system—Behcet's disease	0.00143	0.0024	CbGeAlD
Nilotinib—EPHA4—brain—Behcet's disease	0.00142	0.00238	CbGeAlD
Nilotinib—PDGFRA—nervous system—Behcet's disease	0.00141	0.00236	CbGeAlD
Nilotinib—CA3—brain—Behcet's disease	0.0014	0.00235	CbGeAlD
Nilotinib—ABL1—cardiac atrium—Behcet's disease	0.00138	0.00232	CbGeAlD
Nilotinib—KIT—midbrain—Behcet's disease	0.00137	0.0023	CbGeAlD
Nilotinib—PDGFRA—central nervous system—Behcet's disease	0.00136	0.00227	CbGeAlD
Nilotinib—PDGFRB—midbrain—Behcet's disease	0.00134	0.00224	CbGeAlD
Nilotinib—KIT—spinal cord—Behcet's disease	0.00134	0.00224	CbGeAlD
Nilotinib—MAPK14—brain—Behcet's disease	0.00131	0.0022	CbGeAlD
Nilotinib—PDGFRB—spinal cord—Behcet's disease	0.0013	0.00219	CbGeAlD
Nilotinib—ABL1—medulla oblongata—Behcet's disease	0.0013	0.00219	CbGeAlD
Nilotinib—FGR—brain—Behcet's disease	0.0013	0.00219	CbGeAlD
Nilotinib—CA12—nervous system—Behcet's disease	0.0013	0.00218	CbGeAlD
Nilotinib—CA14—brain—Behcet's disease	0.00127	0.00214	CbGeAlD
Nilotinib—CA2—brainstem—Behcet's disease	0.00127	0.00214	CbGeAlD
Nilotinib—MAP2K5—nervous system—Behcet's disease	0.00127	0.00213	CbGeAlD
Nilotinib—CA12—central nervous system—Behcet's disease	0.00125	0.0021	CbGeAlD
Nilotinib—EPHB4—brain—Behcet's disease	0.00124	0.00208	CbGeAlD
Nilotinib—CA2—eye—Behcet's disease	0.00124	0.00208	CbGeAlD
Nilotinib—CSF1R—nervous system—Behcet's disease	0.00124	0.00208	CbGeAlD
Nilotinib—CA2—retina—Behcet's disease	0.00123	0.00206	CbGeAlD
Nilotinib—MAP2K5—central nervous system—Behcet's disease	0.00122	0.00205	CbGeAlD
Nilotinib—CA1—spinal cord—Behcet's disease	0.00122	0.00205	CbGeAlD
Nilotinib—EPHA2—brain—Behcet's disease	0.00122	0.00204	CbGeAlD
Nilotinib—CSF1R—central nervous system—Behcet's disease	0.00119	0.002	CbGeAlD
Nilotinib—ABL1—midbrain—Behcet's disease	0.00119	0.002	CbGeAlD
Nilotinib—TEK—brain—Behcet's disease	0.00119	0.00199	CbGeAlD
Nilotinib—ABL1—spinal cord—Behcet's disease	0.00116	0.00195	CbGeAlD
Nilotinib—CA4—cardiac atrium—Behcet's disease	0.00114	0.00191	CbGeAlD
Nilotinib—EPHB6—brain—Behcet's disease	0.00114	0.0019	CbGeAlD
Nilotinib—KIT—nervous system—Behcet's disease	0.00113	0.00189	CbGeAlD
Nilotinib—PDGFRB—nervous system—Behcet's disease	0.0011	0.00184	CbGeAlD
Nilotinib—KIT—central nervous system—Behcet's disease	0.00108	0.00182	CbGeAlD
Nilotinib—CA2—skin of body—Behcet's disease	0.00108	0.00181	CbGeAlD
Nilotinib—PDGFRA—brain—Behcet's disease	0.00108	0.00181	CbGeAlD
Nilotinib—CA4—medulla oblongata—Behcet's disease	0.00107	0.0018	CbGeAlD
Nilotinib—ABCB1—blood vessel—Behcet's disease	0.00106	0.00179	CbGeAlD
Nilotinib—PDGFRB—central nervous system—Behcet's disease	0.00106	0.00178	CbGeAlD
Nilotinib—CA1—nervous system—Behcet's disease	0.00103	0.00173	CbGeAlD
Nilotinib—CA12—brain—Behcet's disease	0.000993	0.00167	CbGeAlD
Nilotinib—CA1—central nervous system—Behcet's disease	0.000991	0.00166	CbGeAlD
Nilotinib—CA2—mammalian vulva—Behcet's disease	0.000984	0.00165	CbGeAlD
Nilotinib—ABL1—nervous system—Behcet's disease	0.00098	0.00164	CbGeAlD
Nilotinib—CA4—midbrain—Behcet's disease	0.000979	0.00164	CbGeAlD
Nilotinib—MAP2K5—brain—Behcet's disease	0.000971	0.00163	CbGeAlD
Nilotinib—CA4—spinal cord—Behcet's disease	0.000955	0.0016	CbGeAlD
Nilotinib—CSF1R—brain—Behcet's disease	0.000948	0.00159	CbGeAlD
Nilotinib—ABL1—central nervous system—Behcet's disease	0.000944	0.00158	CbGeAlD
Nilotinib—CA2—cardiac atrium—Behcet's disease	0.000942	0.00158	CbGeAlD
Nilotinib—CYP2B6—skin of body—Behcet's disease	0.000922	0.00155	CbGeAlD
Nilotinib—ABCG2—mammalian vulva—Behcet's disease	0.000911	0.00153	CbGeAlD
Nilotinib—CA2—medulla oblongata—Behcet's disease	0.000888	0.00149	CbGeAlD
Nilotinib—KIT—brain—Behcet's disease	0.00086	0.00144	CbGeAlD
Nilotinib—PDGFRB—brain—Behcet's disease	0.00084	0.00141	CbGeAlD
Nilotinib—ABCG2—medulla oblongata—Behcet's disease	0.000823	0.00138	CbGeAlD
Nilotinib—CA2—midbrain—Behcet's disease	0.000812	0.00136	CbGeAlD
Nilotinib—CYP2D6—brainstem—Behcet's disease	0.000809	0.00136	CbGeAlD
Nilotinib—CA4—nervous system—Behcet's disease	0.000805	0.00135	CbGeAlD
Nilotinib—CA2—spinal cord—Behcet's disease	0.000792	0.00133	CbGeAlD
Nilotinib—CA1—brain—Behcet's disease	0.000787	0.00132	CbGeAlD
Nilotinib—CA4—central nervous system—Behcet's disease	0.000775	0.0013	CbGeAlD
Nilotinib—ABCG2—midbrain—Behcet's disease	0.000752	0.00126	CbGeAlD
Nilotinib—ABL1—brain—Behcet's disease	0.000749	0.00126	CbGeAlD
Nilotinib—ABCG2—spinal cord—Behcet's disease	0.000733	0.00123	CbGeAlD
Nilotinib—CA2—nervous system—Behcet's disease	0.000667	0.00112	CbGeAlD
Nilotinib—CA2—central nervous system—Behcet's disease	0.000642	0.00108	CbGeAlD
Nilotinib—CA4—brain—Behcet's disease	0.000615	0.00103	CbGeAlD
Nilotinib—CYP2B6—nervous system—Behcet's disease	0.00057	0.000957	CbGeAlD
Nilotinib—ABCB1—retina—Behcet's disease	0.000561	0.000941	CbGeAlD
Nilotinib—CYP2B6—central nervous system—Behcet's disease	0.000549	0.000921	CbGeAlD
Nilotinib—CA2—brain—Behcet's disease	0.00051	0.000856	CbGeAlD
Nilotinib—CYP2C8—brain—Behcet's disease	0.000486	0.000815	CbGeAlD
Nilotinib—ABCG2—brain—Behcet's disease	0.000472	0.000793	CbGeAlD
Nilotinib—ABCB1—mammalian vulva—Behcet's disease	0.000449	0.000754	CbGeAlD
Nilotinib—CYP2B6—brain—Behcet's disease	0.000436	0.000731	CbGeAlD
Nilotinib—CYP3A4—nervous system—Behcet's disease	0.000431	0.000722	CbGeAlD
Nilotinib—CYP2D6—nervous system—Behcet's disease	0.000424	0.000711	CbGeAlD
Nilotinib—CYP3A4—central nervous system—Behcet's disease	0.000414	0.000695	CbGeAlD
Nilotinib—CYP2D6—central nervous system—Behcet's disease	0.000408	0.000684	CbGeAlD
Nilotinib—ABCB1—medulla oblongata—Behcet's disease	0.000406	0.00068	CbGeAlD
Nilotinib—ABCB1—midbrain—Behcet's disease	0.000371	0.000622	CbGeAlD
Nilotinib—ABCB1—spinal cord—Behcet's disease	0.000362	0.000607	CbGeAlD
Nilotinib—CYP2D6—brain—Behcet's disease	0.000324	0.000543	CbGeAlD
Nilotinib—ABCB1—nervous system—Behcet's disease	0.000305	0.000511	CbGeAlD
Nilotinib—ABCB1—central nervous system—Behcet's disease	0.000293	0.000492	CbGeAlD
Nilotinib—LYN—Immune System—ITGB2—Behcet's disease	0.00024	0.000594	CbGpPWpGaD
Nilotinib—ABL1—Immune System—ITGB2—Behcet's disease	0.000239	0.000591	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—SERPINE1—Behcet's disease	0.000237	0.000587	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—TNF—Behcet's disease	0.000233	0.000577	CbGpPWpGaD
Nilotinib—ABCB1—brain—Behcet's disease	0.000233	0.000391	CbGeAlD
Nilotinib—CA12—Metabolism—CAT—Behcet's disease	0.000231	0.000573	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—TNF—Behcet's disease	0.000231	0.000571	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—TNF—Behcet's disease	0.000231	0.000571	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—CXCL8—Behcet's disease	0.000229	0.000567	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—ITGB2—Behcet's disease	0.000228	0.000563	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—APOB—Behcet's disease	0.000227	0.000562	CbGpPWpGaD
Nilotinib—LCK—Platelet activation, signaling and aggregation—SERPINE1—Behcet's disease	0.000227	0.000562	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—HLA-B—Behcet's disease	0.000227	0.000561	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—NOS3—Behcet's disease	0.000226	0.00056	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—APOB—Behcet's disease	0.000226	0.00056	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000225	0.000556	CbGpPWpGaD
Nilotinib—CA12—Metabolism—APOB—Behcet's disease	0.000225	0.000556	CbGpPWpGaD
Nilotinib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—Behcet's disease	0.000224	0.000555	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—TNF—Behcet's disease	0.000223	0.000553	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—ITGAL—Behcet's disease	0.000221	0.000547	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—HLA-B—Behcet's disease	0.000218	0.000539	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—TNF—Behcet's disease	0.000217	0.000537	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CCR1—Behcet's disease	0.000217	0.000536	CbGpPWpGaD
Nilotinib—LYN—Immune System—ITGAL—Behcet's disease	0.000216	0.000536	CbGpPWpGaD
Nilotinib—ABL1—Immune System—ITGAL—Behcet's disease	0.000215	0.000533	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—APOB—Behcet's disease	0.000215	0.000533	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CCR1—Behcet's disease	0.000215	0.000531	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—HLA-B—Behcet's disease	0.000215	0.000531	CbGpPWpGaD
Nilotinib—CA14—Metabolism—APOA1—Behcet's disease	0.000211	0.000522	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000208	0.000515	CbGpPWpGaD
Nilotinib—PDGFRB—MAPK Signaling Pathway—TNF—Behcet's disease	0.000208	0.000514	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—HLA-B—Behcet's disease	0.000206	0.00051	CbGpPWpGaD
Nilotinib—CA6—Metabolism—APOA1—Behcet's disease	0.000205	0.000509	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—ITGAL—Behcet's disease	0.000205	0.000508	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—TNF—Behcet's disease	0.000204	0.000505	CbGpPWpGaD
Nilotinib—HCK—Immune System—HLA-B—Behcet's disease	0.000203	0.000502	CbGpPWpGaD
Nilotinib—HCK—Disease—APOB—Behcet's disease	0.000202	0.000501	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—CTLA4—Behcet's disease	0.000201	0.000498	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—CTLA4—Behcet's disease	0.000198	0.00049	CbGpPWpGaD
Nilotinib—LCK—Immune System—ITGB2—Behcet's disease	0.000197	0.000487	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CCR1—Behcet's disease	0.000195	0.000484	CbGpPWpGaD
Nilotinib—PDGFRB—Innate Immune System—HLA-B—Behcet's disease	0.000193	0.000478	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—CXCL8—Behcet's disease	0.000193	0.000477	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—TNF—Behcet's disease	0.000193	0.000477	CbGpPWpGaD
Nilotinib—CA7—Metabolism—APOA1—Behcet's disease	0.000192	0.000475	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—HLA-B—Behcet's disease	0.000189	0.000468	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—HLA-B—Behcet's disease	0.000188	0.000466	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—TNF—Behcet's disease	0.000188	0.000465	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—APOB—Behcet's disease	0.000186	0.000461	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—HLA-B—Behcet's disease	0.000186	0.000459	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CCR1—Behcet's disease	0.000185	0.000458	CbGpPWpGaD
Nilotinib—CA4—Metabolism—CAT—Behcet's disease	0.000184	0.000457	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HLA-B—Behcet's disease	0.000184	0.000455	CbGpPWpGaD
Nilotinib—BLK—Immune System—HLA-B—Behcet's disease	0.000184	0.000455	CbGpPWpGaD
Nilotinib—FGR—Immune System—HLA-B—Behcet's disease	0.000183	0.000453	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000182	0.000452	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—HLA-B—Behcet's disease	0.000182	0.00045	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—APOA1—Behcet's disease	0.00018	0.000445	CbGpPWpGaD
Nilotinib—MAPK14—Innate Immune System—HLA-B—Behcet's disease	0.000179	0.000444	CbGpPWpGaD
Nilotinib—CA4—Metabolism—APOB—Behcet's disease	0.000179	0.000443	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—APOA1—Behcet's disease	0.000179	0.000443	CbGpPWpGaD
Nilotinib—KIT—Immune System—CTLA4—Behcet's disease	0.000178	0.000442	CbGpPWpGaD
Nilotinib—CA12—Metabolism—APOA1—Behcet's disease	0.000178	0.00044	CbGpPWpGaD
Nilotinib—LCK—Immune System—ITGAL—Behcet's disease	0.000177	0.000439	CbGpPWpGaD
Nilotinib—CA2—Metabolism—CAT—Behcet's disease	0.000177	0.000438	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—ICAM1—Behcet's disease	0.000177	0.000438	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000174	0.00043	CbGpPWpGaD
Nilotinib—CA2—Metabolism—APOB—Behcet's disease	0.000172	0.000425	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—APOA1—Behcet's disease	0.00017	0.000422	CbGpPWpGaD
Nilotinib—CA1—Metabolism—CAT—Behcet's disease	0.00017	0.00042	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CTLA4—Behcet's disease	0.000169	0.000418	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—ICAM1—Behcet's disease	0.000167	0.000414	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CCR1—Behcet's disease	0.000167	0.000413	CbGpPWpGaD
Nilotinib—HCK—Immune System—ICAM1—Behcet's disease	0.000165	0.000408	CbGpPWpGaD
Nilotinib—CA1—Metabolism—APOB—Behcet's disease	0.000165	0.000407	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CCR1—Behcet's disease	0.000163	0.000404	CbGpPWpGaD
Nilotinib—HCK—Disease—APOA1—Behcet's disease	0.00016	0.000396	CbGpPWpGaD
Nilotinib—CA14—Metabolism—NOS3—Behcet's disease	0.00016	0.000395	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000159	0.000395	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000156	0.000387	CbGpPWpGaD
Nilotinib—CA6—Metabolism—NOS3—Behcet's disease	0.000156	0.000385	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—HLA-B—Behcet's disease	0.000155	0.000384	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CCR1—Behcet's disease	0.000155	0.000383	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CTLA4—Behcet's disease	0.000152	0.000377	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—ICAM1—Behcet's disease	0.000151	0.000373	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—ICAM1—Behcet's disease	0.000149	0.00037	CbGpPWpGaD
Nilotinib—BLK—Immune System—ICAM1—Behcet's disease	0.000149	0.00037	CbGpPWpGaD
Nilotinib—CA9—Metabolism—CAT—Behcet's disease	0.000149	0.000369	CbGpPWpGaD
Nilotinib—LYN—Immune System—CTLA4—Behcet's disease	0.000149	0.000369	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-B—Behcet's disease	0.000149	0.000369	CbGpPWpGaD
Nilotinib—FGR—Immune System—ICAM1—Behcet's disease	0.000149	0.000368	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CTLA4—Behcet's disease	0.000148	0.000367	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—ICAM1—Behcet's disease	0.000148	0.000365	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—APOA1—Behcet's disease	0.000147	0.000365	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-B—Behcet's disease	0.000146	0.000362	CbGpPWpGaD
Nilotinib—CA7—Metabolism—NOS3—Behcet's disease	0.000145	0.00036	CbGpPWpGaD
Nilotinib—BRAF—Disease—APOB—Behcet's disease	0.000145	0.000358	CbGpPWpGaD
Nilotinib—CA9—Metabolism—APOB—Behcet's disease	0.000145	0.000358	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—SERPINE1—Behcet's disease	0.000143	0.000353	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—SERPINE1—Behcet's disease	0.000142	0.000352	CbGpPWpGaD
Nilotinib—CA4—Metabolism—APOA1—Behcet's disease	0.000142	0.000351	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CTLA4—Behcet's disease	0.000141	0.00035	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—NOS3—Behcet's disease	0.000136	0.000337	CbGpPWpGaD
Nilotinib—CA2—Metabolism—APOA1—Behcet's disease	0.000136	0.000336	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—NOS3—Behcet's disease	0.000136	0.000336	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—SERPINE1—Behcet's disease	0.000135	0.000335	CbGpPWpGaD
Nilotinib—CA12—Metabolism—NOS3—Behcet's disease	0.000135	0.000333	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CCR1—Behcet's disease	0.000134	0.000331	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-B—Behcet's disease	0.000132	0.000327	CbGpPWpGaD
Nilotinib—KIT—Disease—APOB—Behcet's disease	0.000132	0.000326	CbGpPWpGaD
Nilotinib—CA1—Metabolism—APOA1—Behcet's disease	0.00013	0.000322	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—NOS3—Behcet's disease	0.000129	0.00032	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—APOB—Behcet's disease	0.000128	0.000318	CbGpPWpGaD
Nilotinib—HCK—Disease—SERPINE1—Behcet's disease	0.000127	0.000315	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-B—Behcet's disease	0.000125	0.000309	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—APOB—Behcet's disease	0.000125	0.000309	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000124	0.000306	CbGpPWpGaD
Nilotinib—LCK—Immune System—CTLA4—Behcet's disease	0.000122	0.000302	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—APOB—Behcet's disease	0.000122	0.000302	CbGpPWpGaD
Nilotinib—HCK—Disease—NOS3—Behcet's disease	0.000121	0.0003	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—ICAM1—Behcet's disease	0.000121	0.0003	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—ICAM1—Behcet's disease	0.000119	0.000294	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—SERPINE1—Behcet's disease	0.000117	0.000289	CbGpPWpGaD
Nilotinib—BRAF—Disease—APOA1—Behcet's disease	0.000114	0.000283	CbGpPWpGaD
Nilotinib—CA9—Metabolism—APOA1—Behcet's disease	0.000114	0.000283	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—TNF—Behcet's disease	0.000114	0.000282	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-B—Behcet's disease	0.000113	0.000279	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—APOB—Behcet's disease	0.000112	0.000278	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—NOS3—Behcet's disease	0.000112	0.000276	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-B—Behcet's disease	0.00011	0.000273	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-B—Behcet's disease	0.00011	0.000272	CbGpPWpGaD
Nilotinib—CA4—Metabolism—NOS3—Behcet's disease	0.000107	0.000266	CbGpPWpGaD
Nilotinib—KIT—Immune System—ICAM1—Behcet's disease	0.000107	0.000265	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-B—Behcet's disease	0.000104	0.000259	CbGpPWpGaD
Nilotinib—KIT—Disease—APOA1—Behcet's disease	0.000104	0.000258	CbGpPWpGaD
Nilotinib—CA2—Metabolism—NOS3—Behcet's disease	0.000103	0.000255	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—APOB—Behcet's disease	0.000102	0.000253	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000102	0.000252	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—APOA1—Behcet's disease	0.000102	0.000251	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—ICAM1—Behcet's disease	0.000102	0.000251	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—APOB—Behcet's disease	0.000101	0.000251	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—SERPINE1—Behcet's disease	9.88e-05	0.000245	CbGpPWpGaD
Nilotinib—CA1—Metabolism—NOS3—Behcet's disease	9.87e-05	0.000244	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—APOA1—Behcet's disease	9.86e-05	0.000244	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—APOA1—Behcet's disease	9.66e-05	0.000239	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—APOB—Behcet's disease	9.22e-05	0.000228	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—ICAM1—Behcet's disease	9.15e-05	0.000226	CbGpPWpGaD
Nilotinib—BRAF—Disease—SERPINE1—Behcet's disease	9.09e-05	0.000225	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-B—Behcet's disease	9.03e-05	0.000224	CbGpPWpGaD
Nilotinib—LCK—Disease—APOB—Behcet's disease	9.01e-05	0.000223	CbGpPWpGaD
Nilotinib—LYN—Immune System—ICAM1—Behcet's disease	8.95e-05	0.000222	CbGpPWpGaD
Nilotinib—ABL1—Immune System—ICAM1—Behcet's disease	8.91e-05	0.000221	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—APOA1—Behcet's disease	8.89e-05	0.00022	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CAT—Behcet's disease	8.88e-05	0.00022	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—APOB—Behcet's disease	8.73e-05	0.000216	CbGpPWpGaD
Nilotinib—BRAF—Disease—NOS3—Behcet's disease	8.68e-05	0.000215	CbGpPWpGaD
Nilotinib—CA9—Metabolism—NOS3—Behcet's disease	8.68e-05	0.000215	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—APOB—Behcet's disease	8.62e-05	0.000213	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TNF—Behcet's disease	8.57e-05	0.000212	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TNF—Behcet's disease	8.53e-05	0.000211	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—ICAM1—Behcet's disease	8.49e-05	0.00021	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	8.44e-05	0.000209	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	8.29e-05	0.000205	CbGpPWpGaD
Nilotinib—KIT—Disease—SERPINE1—Behcet's disease	8.27e-05	0.000205	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TNF—Behcet's disease	8.13e-05	0.000201	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—APOA1—Behcet's disease	8.09e-05	0.0002	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—SERPINE1—Behcet's disease	8.06e-05	0.0002	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	8.06e-05	0.0002	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—APOA1—Behcet's disease	8.02e-05	0.000198	CbGpPWpGaD
Nilotinib—KIT—Disease—NOS3—Behcet's disease	7.9e-05	0.000195	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	7.87e-05	0.000195	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—APOB—Behcet's disease	7.87e-05	0.000195	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—SERPINE1—Behcet's disease	7.83e-05	0.000194	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—APOB—Behcet's disease	7.7e-05	0.000191	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—NOS3—Behcet's disease	7.7e-05	0.000191	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—SERPINE1—Behcet's disease	7.67e-05	0.00019	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CAT—Behcet's disease	7.53e-05	0.000186	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—NOS3—Behcet's disease	7.48e-05	0.000185	CbGpPWpGaD
Nilotinib—LCK—Immune System—ICAM1—Behcet's disease	7.34e-05	0.000182	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NOS3—Behcet's disease	7.32e-05	0.000181	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—APOB—Behcet's disease	7.31e-05	0.000181	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—APOB—Behcet's disease	7.3e-05	0.000181	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—APOA1—Behcet's disease	7.3e-05	0.000181	CbGpPWpGaD
Nilotinib—LCK—Disease—APOA1—Behcet's disease	7.13e-05	0.000177	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—SERPINE1—Behcet's disease	7.05e-05	0.000175	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—SERPINE1—Behcet's disease	7.05e-05	0.000175	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—APOA1—Behcet's disease	6.91e-05	0.000171	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—CXCL8—Behcet's disease	6.83e-05	0.000169	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—APOA1—Behcet's disease	6.82e-05	0.000169	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NOS3—Behcet's disease	6.73e-05	0.000167	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	6.68e-05	0.000165	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	6.56e-05	0.000162	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—CXCL8—Behcet's disease	6.49e-05	0.000161	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—SERPINE1—Behcet's disease	6.42e-05	0.000159	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SERPINE1—Behcet's disease	6.36e-05	0.000158	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—APOB—Behcet's disease	6.31e-05	0.000156	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—APOA1—Behcet's disease	6.22e-05	0.000154	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NOS3—Behcet's disease	6.13e-05	0.000152	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—APOA1—Behcet's disease	6.09e-05	0.000151	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NOS3—Behcet's disease	6.08e-05	0.00015	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SERPINE1—Behcet's disease	5.79e-05	0.000143	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—APOA1—Behcet's disease	5.79e-05	0.000143	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—APOA1—Behcet's disease	5.78e-05	0.000143	CbGpPWpGaD
Nilotinib—LCK—Disease—SERPINE1—Behcet's disease	5.66e-05	0.00014	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NOS3—Behcet's disease	5.53e-05	0.000137	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CAT—Behcet's disease	5.52e-05	0.000137	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SERPINE1—Behcet's disease	5.48e-05	0.000136	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—CXCL8—Behcet's disease	5.44e-05	0.000135	CbGpPWpGaD
Nilotinib—LCK—Disease—NOS3—Behcet's disease	5.4e-05	0.000134	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—CXCL8—Behcet's disease	5.39e-05	0.000133	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—APOB—Behcet's disease	5.36e-05	0.000133	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NOS3—Behcet's disease	5.23e-05	0.00013	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—NOS3—Behcet's disease	5.17e-05	0.000128	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—APOA1—Behcet's disease	4.99e-05	0.000124	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SERPINE1—Behcet's disease	4.94e-05	0.000122	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—CXCL8—Behcet's disease	4.91e-05	0.000121	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SERPINE1—Behcet's disease	4.84e-05	0.00012	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NOS3—Behcet's disease	4.72e-05	0.000117	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CAT—Behcet's disease	4.67e-05	0.000116	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—CXCL8—Behcet's disease	4.64e-05	0.000115	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NOS3—Behcet's disease	4.62e-05	0.000114	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SERPINE1—Behcet's disease	4.58e-05	0.000113	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—APOB—Behcet's disease	4.54e-05	0.000112	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—NOS3—Behcet's disease	4.38e-05	0.000109	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NOS3—Behcet's disease	4.38e-05	0.000108	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—APOA1—Behcet's disease	4.24e-05	0.000105	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CXCL8—Behcet's disease	4.18e-05	0.000104	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CXCL8—Behcet's disease	4.1e-05	0.000101	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CAT—Behcet's disease	4.07e-05	0.000101	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SERPINE1—Behcet's disease	3.96e-05	9.81e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—APOB—Behcet's disease	3.95e-05	9.79e-05	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CXCL8—Behcet's disease	3.88e-05	9.61e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CAT—Behcet's disease	3.84e-05	9.5e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CAT—Behcet's disease	3.8e-05	9.42e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NOS3—Behcet's disease	3.78e-05	9.37e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—APOB—Behcet's disease	3.73e-05	9.22e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—APOB—Behcet's disease	3.69e-05	9.14e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—APOA1—Behcet's disease	3.59e-05	8.89e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CXCL8—Behcet's disease	3.36e-05	8.31e-05	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—NOS3—Behcet's disease	3.21e-05	7.96e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—APOA1—Behcet's disease	3.13e-05	7.74e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—APOA1—Behcet's disease	2.95e-05	7.3e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—APOA1—Behcet's disease	2.92e-05	7.23e-05	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—NOS3—Behcet's disease	2.72e-05	6.74e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CAT—Behcet's disease	2.51e-05	6.21e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—APOB—Behcet's disease	2.44e-05	6.03e-05	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NOS3—Behcet's disease	2.37e-05	5.87e-05	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NOS3—Behcet's disease	2.23e-05	5.53e-05	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NOS3—Behcet's disease	2.21e-05	5.48e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—APOA1—Behcet's disease	1.93e-05	4.77e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NOS3—Behcet's disease	1.46e-05	3.62e-05	CbGpPWpGaD
